Search by Drug Name or NDC

    NDC 11673-0010-71 up and up famotidine complete 800; 10; 165 mg/1; mg/1; mg/1 Details

    up and up famotidine complete 800; 10; 165 mg/1; mg/1; mg/1

    up and up famotidine complete is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE.

    Product Information

    NDC 11673-0010
    Product ID 11673-010_467d1aa6-b363-4314-9806-e4f4a495bdab
    Associated GPIs
    GCN Sequence Number 047669
    GCN Sequence Number Description famotidine/Ca carb/mag hydrox TAB CHEW 10-800-165 ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 13069
    HICL Sequence Number 021332
    HICL Sequence Number Description FAMOTIDINE/CALCIUM CARBONATE/MAGNESIUM HYDROXIDE
    Brand/Generic Generic
    Proprietary Name up and up famotidine complete
    Proprietary Name Suffix n/a
    Non-Proprietary Name Famotidine, Calcium Carbonate, Magnesium Hydroxide
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, CHEWABLE
    Route ORAL
    Active Ingredient Strength 800; 10; 165
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
    Labeler Name Target Corporation
    Pharmaceutical Class Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Elect
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077355
    Listing Certified Through 2024-12-31

    Package

    NDC 11673-0010-71 (11673001071)

    NDC Package Code 11673-010-71
    Billing NDC 11673001071
    Package 50 TABLET, CHEWABLE in 1 BOTTLE (11673-010-71)
    Marketing Start Date 2015-05-06
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 1dd5004a-04d4-4297-bd54-a55c3b9e8d3f Details

    Revised: 10/2022